Skip to main content
Account

Peer review reports

From: Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units

Original Submission
5 Jul 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
5 Sep 2023 Reviewed Reviewer Report - Gabriel Trova Cuba
14 Sep 2023 Reviewed Reviewer Report
4 Oct 2023 Author responded Author comments - Lan Zhang
Resubmission - Version 4
4 Oct 2023 Submitted Manuscript version 4
6 Oct 2023 Author responded Author comments - Lan Zhang
Resubmission - Version 5
6 Oct 2023 Submitted Manuscript version 5
6 Oct 2023 Author responded Author comments - Lan Zhang
Resubmission - Version 6
6 Oct 2023 Submitted Manuscript version 6
9 Oct 2023 Author responded Author comments - Lan Zhang
Resubmission - Version 7
9 Oct 2023 Submitted Manuscript version 7
10 Oct 2023 Author responded Author comments - Lan Zhang
Resubmission - Version 8
10 Oct 2023 Submitted Manuscript version 8
11 Oct 2023 Author responded Author comments - Lan Zhang
Resubmission - Version 9
11 Oct 2023 Submitted Manuscript version 9
16 Oct 2023 Author responded Author comments - Lan Zhang
Resubmission - Version 10
16 Oct 2023 Submitted Manuscript version 10
18 Oct 2023 Author responded Author comments - Lan Zhang
Resubmission - Version 11
18 Oct 2023 Submitted Manuscript version 11
Publishing
13 Nov 2023 Editorially accepted
27 Nov 2023 Article published 10.1186/s12879-023-08815-7

Learn about peer review

Back to article page

Navigation